IPCA Laboratories has entered into an agreement with Avik Pharmaceutical (Avik) to acquire 50% of its paid-up equity share capital, partly through purchase of equity shares from its existing shareholders and partly thru subscription to its fresh equity share capital on a preferential allotment basis, both aggregating to approximately Rs 6.51 crore.
Epic Research
Tuesday, November 19, 2013
Epic Update : IPCA Laboratories
Labels:
Best Stock Tips,
Best Tips For Intraday,
Bullion Tips,
Commodity Tips,
equity tips,
Equity Tips Free Trial,
Forex Tips,
Forex Tips MCX Tips,
Free Trial,
MCX Tips,
NCDEX Tips,
NCDEX Tips.,
Penny Stock Tips,
share market,
share tips,
share tips india,
stock tips,
stock tips india,
Stock Trading Tips.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment